EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low, Intermediate, and High Glutamine Levels Are Progressively Associated with Increased Lymphopenia, a Diminished Inflammatory Response, and Higher Mortality in Internal Medicine Patients with Sepsis

Filippo Mearelli iD, Alessio Nunnari iD, Federica Chitti, Annalisa Rombini, Alessandra Macor, Donatella Denora, Luca Messana, Marianna Scardino, Ilaria Martini, Giulia Bolzan, Noemi Merlo, Fabio Di Paola und 10 weitere

Journal of Clinical Medicine · 09.05.2025 · 14 (10) · 3313

DOI: 10.3390/jcm14103313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.05.2025. Verfasst von Filippo Mearelli und 21 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Internal Medicine, Clinica Medica, Department of Medical Surgical and Health Sciences, University of Trieste, Strada di Fiume 447, 34100 Trie…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union X-BRAIN.NET.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pathophysiological mechanisms underlying altered plasma glutamine concentrations in sepsis remain poorly understood. Identifying clinical, immunological, and metabolic correlates of glutamine fluctuations is crucial to advancing precision medicine, developing targeted therapies, and improving survival outcomes in septic patients.

Methods

We enrolled 469 patients with sepsis and assessed inflammatory markers—including body temperature, white blood cell count, and C-reactive protein levels—upon admission to the internal medicine unit. Lymphocyte count and plasma concentrations of glutamine, glutamic acid, 5-oxoproline, phenylalanine, tyrosine, and leucine were measured using gas chromatography–mass spectrometry. Patients were stratified into three groups based on plasma glutamine levels. Mortality was recorded at 30 days and 6 months.

Results

Low, intermediate, and high glutamine levels were observed in 46% (n = 217), 47% (n = 218), and 7% (n = 34) of patients, respectively. Patients with hyperglutaminemia exhibited significantly lower body temperature, white blood cell and lymphocyte counts, C-reactive protein levels, and glutamic acid-to-5-oxoproline ratio (a surrogate marker of glutathione availability), along with elevated phenylalanine levels, leucine levels, and tyrosine-to-phenylalanine ratio (all p < 0.01). Metabolic disruption and mortality increased progressively across glutamine level groups. Kaplan–Meier analysis demonstrated significantly higher mortality in patients with elevated glutamine levels at both 30 days (log-rank p = 0.03) and 6 months (log-rank p = 0.05).

Conclusions

At baseline, increasing plasma glutamine levels are associated with progressively deeper lymphopenia, more pronounced metabolic derangement, and higher short- and long-term mortality in patients with sepsis.

Schlagwörter

Stichwörter der Autor:innen

5-oxoprolineglutamic acidglutamineleucinephenylalanine/tyrosinesepsis

Autor:innen und Institutionen

  • Unit of Internal Medicine, Clinica Medica, Department of Medical Surgical and Health Sciences, University of Trieste, Strada di Fiume 447, 34100 Trieste, Italy.
  • Microbiology Unit, University Hospital (ASUGI), Strada di Fiume n° 447, 34137 Trieste, Italy.
  • Infectious Diseases Unit, Clinical Departement of Medical, Surgical, and Health Sciences, University Hospital (ASUGI), Piazzale dell'Ospedale n° 1, 34129 Trieste, Italy.
  • Infectious Diseases Unit, University Hospital (ASUFC), Via Pozzuolo n° 330, 33100 Udine, Italy.
  • Department of Anesthesia and Intensive Care, University Hospital (ASUFC), Via Pozzuolo n° 330, 33100 Udine, Italy.

ORCID-Profile: Filippo Mearelli, Alessio Nunnari, Nicola Fiotti, Venera Costantino, Verena Zerbato, Stefano Di Bella, Carlo Tascini, Daniele Orso, Gianni Biolo

Förderung

  • European Union X-BRAIN.NET

Zitieren

APA

Mearelli, F., Nunnari, A., Chitti, F., Rombini, A., Macor, A., Denora, D., Messana, L., Scardino, M., Martini, I., Bolzan, G., Merlo, N., Di Paola, F., Spagnol, F., Casarsa, C., Fiotti, N., Costantino, V., Zerbato, V., Di Bella, S., Tascini, C., …, & Biolo, G. (2025). Low, Intermediate, and High Glutamine Levels Are Progressively Associated with Increased Lymphopenia, a Diminished Inflammatory Response, and Higher Mortality in Internal Medicine Patients with Sepsis. Journal of Clinical Medicine, 14(10), 3313. https://doi.org/10.3390/jcm14103313

Vancouver

Mearelli F, Nunnari A, Chitti F, Rombini A, Macor A, Denora D, et al. Low, Intermediate, and High Glutamine Levels Are Progressively Associated with Increased Lymphopenia, a Diminished Inflammatory Response, and Higher Mortality in Internal Medicine Patients with Sepsis. Journal of Clinical Medicine. 2025;14(10):3313. doi:10.3390/jcm14103313

BibTeX
@article{Mearelli2025,
  author = {Mearelli, Filippo and Nunnari, Alessio and Chitti, Federica and Rombini, Annalisa and Macor, Alessandra and Denora, Donatella and Messana, Luca and Scardino, Marianna and Martini, Ilaria and Bolzan, Giulia and Merlo, Noemi and Di Paola, Fabio and Spagnol, Francesca and Casarsa, Chiara and Fiotti, Nicola and Costantino, Venera and Zerbato, Verena and Di Bella, Stefano and Tascini, Carlo and Orso, Daniele and Di Girolamo, Filippo Giorgio and Biolo, Gianni},
  title = {Low, Intermediate, and High Glutamine Levels Are Progressively Associated with Increased Lymphopenia, a Diminished Inflammatory Response, and Higher Mortality in Internal Medicine Patients with Sepsis},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {3313},
  doi = {10.3390/jcm14103313}
}
Kostenlos starten →